Company / Depreciation & Amortization
Biogen Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$779.9M
FY2025
5-year range
$487.7M / $779.9M
FY2021-FY2025
Trend
+15.8%
vs FY2024
Sector context
#9 of 162
Health Care
What the data says
Among 162 Health Care companies, Biogen is in the bottom 6% for depreciation & amortization. Depreciation & Amortization has fluctuated over the past 10 years, ranging from $457M in FY2020 to $1.1B in FY2017.
Based on SEC 10-K filings.
$780M in FY2025 with a 5-year CAGR of +11.3%. Top quartile in the Health Care sector.
Increased from $495M to $780M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +14.6%
- 5-Year CAGR
- +11.3%
- 10-Year CAGR
- -
Sector benchmark
+253.7% above sector average
Key checks
Key Insights
- 5-year CAGR of +11.3%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 15.8% year-over-year.
- Ranks #9 out of 162 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $779.9M | +15.8% |
| FY2024 | $673.2M | +36.1% |
| FY2023 | $494.8M | -4.6% |
| FY2022 | $518.4M | +6.3% |
| FY2021 | $487.7M | +6.7% |
| FY2020 | $457.2M | -1.6% |
| FY2019 | $464.7M | -28.6% |
| FY2018 | $650.5M | -39.8% |
| FY2017 | $1.1B | +58.3% |
| FY2016 | $682.7M | +13.7% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026